G1 Therapeutics Inc Forecast and Stock Analysis
Technical GTHX stock analysis for February 15, 2019.
G1 Therapeutics Inc gained 0.14% in the last trading day, rising from $20.96 to $20.99 The price has risen in 6 of the last 10 days and is up by 5% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 48 549 more shares were traded than the day before. In total, 183 207 shares bought and sold for approximately $3.85 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the GTHX stock was $20.99. This is 0.14% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 5.00% from a day low at $20.50 to a day high of $21.53.
30 day high of the GTHX stock price was $22.11 and low was $18.91.
90 day high was $42.81 and low was $15.21.
52 week high for the G1 Therapeutics Inc - $69.57 and low - $15.21.
G1 Therapeutics Inc lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $22.58 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -47.99% during the next 3 months and, with 90% probability hold a price between $1.72 and $11.74 at the end of this period.
G1 Therapeutics Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $21.12. On a fall, the stock will find some support from the long-term average at approximately $20.18. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 60 and the stock is currently not being overbought or oversold
Support & Resistance
G1 Therapeutics Inc finds support from accumulated volume at $20.57.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.03 (5.00%) between high and low. For the last week, the stock has had a daily average volatility of 4.45%.
Our recommended stoploss: $19.71 (-6.08%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
G1 Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.